Dong-A Pharmaceutical동아제약

Credit rating

• AKorea Investors Service · corporate bonds · Rated Feb 26, 2026
• ANICE Investors Service · corporate bonds · Rated Feb 26, 2026
• AKorea Ratings · corporate bonds · Rated May 24, 2024

Bonds outstanding

₩130B in 4 bonds

1. ≤6 months₩40B
2. 6–12 months—
3. 1–2 years₩60B
4. 2–3 years₩30B
5. 3–5 years—
6. Over 5 years—

We read bond filings from Oct 25, 2021; older bonds may be missing.

Due soon vs cash

Due in 6 months

₩40B

Due in 12 months

₩40B

Cash and equivalents

₩184B

Cash from the 2026 H1 statements

How it has moved with rates and the won

Average move of the shares on days the factor changed, over the last year. Describes the past, not a forecast.

• −0.69% per 10 bp rise in KTB 3ysome link · correlation -0.17 over 253 days
• −0.26% per 1% rise in USD/KRWweak link · correlation -0.08 over 253 days